Of the 33.2 million persons infected with human immunodeficiency virus (HIV), one-third are
estimated to also be infected with Mycobacterium tuberculosis. In 2008, there were an …

Human use of antimicrobials in the clinic, community and agricultural systems has driven
selection for resistance in bacteria. Resistance can be selected at antibiotic concentrations …

Abstract The American Thoracic Society, Centers for Disease Control and Prevention, and
Infectious Diseases Society of America jointly sponsored the development of this guideline …

This report updates and combines earlier versions of guidelines for the prevention and
treatment of opportunistic infections (OIs) in HIV-infected adults (ie, persons aged> 18 years) …

Persistence of Mycobacterium tuberculosis remains a significant challenge for the effective
treatment of tuberculosis in humans. In animals that develop necrotic lung lesions following …

Aliment Pharmacol Ther 2012; 35: 209–221 Summary Background Even with the current
most effective treatment regimens, a relevant proportion of patients will fail to eradicate …

Rifamycins inhibit RNA polymerase of most bacterial genera. Rifampicin remains part of
combination therapy for treating tuberculosis (TB), and for treating Gram-positive prosthetic …

Although truly major advances that would revolutionize tuberculosis (TB) diagnosis and
treatment have not been realized, we are beginning to see the innovations that have been …

Several aspects of human immunodeficiency virus (HIV) infection-related tuberculosis (TB)
and its treatment differ from those of TB in HIV-uninfected persons. The risk of TB and the …

Access to antiretroviral therapy is rapidly expanding in resource-limited settings, where
tuberculosis is the most common opportunistic infection. Coadministration of antitubercular …